Cargando…
Clinical implications of different specimen types for nucleic acid testing in two cases of COVID-19
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid test is currently the gold standard for diagnosing coronavirus disease 2019 (COVID-19). This disease requires high-quality viral nucleic acid tests, and selecting the type of specimen from patients, who are at differ...
Autores principales: | Fan, Hengwei, Yu, Xiaqing, Fu, Xiaohui, Zhu, Hengmei, Lv, Zhongwei, Yi, Wanwan, Zhang, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447863/ https://www.ncbi.nlm.nih.gov/pubmed/32840148 http://dx.doi.org/10.1177/0300060520949067 |
Ejemplares similares
-
Risk factors for recurrent positive results of the nucleic acid amplification test for COVID-19 patients: a retrospective study
por: Yi, Wanwan, et al.
Publicado: (2021) -
An 8 miRNA-Based Risk Score System for Predicting the Prognosis of Patients With Papillary Thyroid Cancer
por: Yi, Wanwan, et al.
Publicado: (2020) -
Roles of BMI1 in the Initiation, Progression, and Treatment of Hepatocellular Carcinoma
por: Wang, Ru, et al.
Publicado: (2022) -
Nucleic Acid Test to Diagnose Cryptosporidiosis: Lab
Assessment in Animal and Patient Specimens
por: Crannell, Zachary Austin, et al.
Publicado: (2014) -
Effect of umifenovir (arbidol) versus standard care
on clinical outcome in patients with COVID-19: a retrospective cohort
study
por: Yi, Wanwan, et al.
Publicado: (2023)